Most Read Articles
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
11 Aug 2019
Treatment with low-to-standard dose dual combination therapy of blood pressure (BP)-lowering drugs is more effective than standard-dose monotherapy and does not increase withdrawals due to adverse events, a recent study has shown.
20 Jun 2019
Untreated white coat hypertension (WCH), but not treated white coat effect (WCE), may increase the risk for cardiovascular events and all-cause mortality, suggest the results of a systematic review and meta-analysis. Out-of-office blood pressure (BP) monitoring is thus important in the diagnosis and management of hypertension.
06 Aug 2019
Risk factors for 1-year mortality in heart failure (HF) patients significantly differ between those with and without chronic kidney disease (CKD), especially with regard to the use of beta-blockers or diuretics at discharge, according to a study. This suggests that these patients may benefit from individualized therapies.

Sunway teams up with UK hospital for knowledge exchange

Saras Ramiya
19 Nov 2018
Tan Sri Dato’ Seri Dr Jeffrey Cheah (third from left) and Dr Lee Boon Chye (fourth from left) with a group of dignitaries at the launch.

Sunway Medical Centre is collaborating with Royal Papworth Hospital to facilitate knowledge exchange among cardiology and respiratory experts.

According to founder and chairman of Sunway Group Tan Sri Dato’ Seri Dr Jeffrey Cheah, the Royal Papworth Hospital was chosen as Professor John Wallwork, chairman of the hospital, “pioneered the introduction of heart-lung transplantation in the UK and is internationally recognized for his achievements in clinical transplantation.”

“We are also proud to be collaborating with Royal Papworth in several fields. Royal Papworth Hospital is a world-leading heart and lung hospital, which performed the world’s first heart, lung and liver transplants in 1986,” said Cheah, at the launch of the Cambridge-Royal Papworth-Sunway Heart and Lung Symposium recently.

The collaboration is expected to enhance the standards of clinical training and medical education for healthcare professionals and enable Sunway to participate in cutting-edge research and clinical trials and explore innovations in healthcare.

In an agreement with the University of Cambridge (UC), Sunway Clinical Research Centre was established as the regional site partner of UC’s School of Clinical Medicine. This will lead to clinical trials as well as research and training aimed at prevention, earlier diagnosis and improved treatments for a range of diseases suited to the Asian genetic composition. The centre is the first such venture in the world for UC.

Sunway is also the first accredited cardiac surgical advanced life support (CALS) training centre in Southeast Asia (SEA) with the signing of a tripartite memorandum of understanding (MoU) among Dr Adrian Levine, managing director of CALS-S-Limited UK and CALS founder; Dr Anand Sachithanandan, CALS-SEA clinical director; and Lau Beng Leong, managing director of Sunway Healthcare Group. CALS training courses will begin in 2019 and involve relevant healthcare professionals in Malaysia and the ASEAN region. CALS trains surgeons, anaesthetists, intensivists and intensive care and high-dependency unit nurses to swiftly recognize and effectively treat a cardiac arrest in patients who have had recent open heart surgery.

In line with cutting-edge technology, Sunway acquired the Philips Azurion 7 biplane, the first image-guided therapy system in Southeast Asia which can merge CT scans and live angiographs for precise navigation of the patient’s heart. The device will be used for the diagnosis and treatment of blocked coronary blood vessels and structures in adults and children, even in newborns.

Sunway received the Medical Tourism Hospital of the Year award in Asia Pacific category at the Global Health and Travel 2018 Awards. The award reflects Sunway’s commitment towards the government’s goal of making medical tourism a major income driver for the country’s economy, said Cheah.

“Southeast Asia is increasingly becoming popular with medical tourism and Malaysia is also acting as a healthcare hub for Southeast Asia. We are emphasizing on the setting up of cardiology and fertility centres as our focus for healthcare tourism for Malaysia,” said Dr Lee Boon Chye, deputy minister, Ministry of Health (MOH).

The private sector is encouraged to promote medical tourism as it is a vital source of growth in the economy; an attraction for talented Malaysians to serve the country and can relieve the burden for MOH facilities.

The success of a hospital depends on the management, technology and the consultants and their ability to uphold professionalism and maintain a high standard of patient care, said Lee.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
11 Aug 2019
Treatment with low-to-standard dose dual combination therapy of blood pressure (BP)-lowering drugs is more effective than standard-dose monotherapy and does not increase withdrawals due to adverse events, a recent study has shown.
20 Jun 2019
Untreated white coat hypertension (WCH), but not treated white coat effect (WCE), may increase the risk for cardiovascular events and all-cause mortality, suggest the results of a systematic review and meta-analysis. Out-of-office blood pressure (BP) monitoring is thus important in the diagnosis and management of hypertension.
06 Aug 2019
Risk factors for 1-year mortality in heart failure (HF) patients significantly differ between those with and without chronic kidney disease (CKD), especially with regard to the use of beta-blockers or diuretics at discharge, according to a study. This suggests that these patients may benefit from individualized therapies.